Royalty Pharma (RPRX) Prepaid Assets (2019 - 2026)

Royalty Pharma has disclosed Prepaid Assets across 8 years of filings, most recently posting $6.7 million for Q2 2026.

• In Q2 2026, Prepaid Assets rose 49.51% year-over-year to $6.7 million; the TTM figure through Jun 2026 stood at $6.7 million (up 49.51% YoY), while the FY2025 annual figure was $6.9 million, up 64.63% from the prior year.
• Prepaid Assets came in at $6.7 million for Q2 2026 at Royalty Pharma, down from $10.2 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $90.5 million in Q4 2022 to a low of $2.3 million in Q2 2024.
• Average Prepaid Assets over 5 years is $19.2 million, with a median of $6.1 million recorded in 2025.
• Year-over-year, Prepaid Assets jumped 1265.1% in 2022 and slumped 92.51% in 2023.
• Over 5 years, Prepaid Assets stood at $90.5 million in 2022, then tumbled by 80.07% to $18.0 million in 2023, then plunged by 76.79% to $4.2 million in 2024, then jumped by 64.63% to $6.9 million in 2025, then retreated by 3.44% to $6.7 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $6.7 million in Q2 2026, $10.2 million in Q1 2026, and $6.9 million in Q4 2025.